LGALS1 and prostate carcinoma: Accordingly, it has been demonstrated that Gal-1 is highly overexpressed in castrate resistant prostate cancer (CRPC) and its knockdown significantly decreases prostate cancer cell migration and invasion (Shih et al. 2018).